Skip to main content
CBD for treatment of epilepsy in dogs

AKC Grants $356 Thousand To Study CBD as Treatment for Epilepsy in Dogs

The American Kennel Club recently announced a grant of $356,000 through its Canine Health Foundation to study the effectiveness of CBD as a treatment for intractable epilepsy in dogs.

Epilepsy is the most common neurological disorder found in dogs. It affects both purebred and mixed breed dogs. Up to a third of dogs undergoing standard anti-epileptic therapy for their seizures do not respond to treatment, and the side effects can be unacceptable. Board-certified veterinary neurologist, Dr. Stephanie McGrath at Colorado State University’s College of Veterinary Medicine and Biomedical Sciences says more effective treatments are desperately needed.

"The timeliness and importance of research into the role of Cannabis in veterinary medicine cannot be emphasized enough," stated Dr. McGrath. "With the changing public perception of Cannabis, it is time that we put science behind the stories and claims. We need to know if this drug is safe and if it works. If CBD is effective for treating epilepsy, it has the potential to save the lives of dogs around the world."

"This study has the potential to provide a much-needed new tool for veterinarians to treat dogs with epilepsy," said Dr. Mary Smith, CHF Director and the Chairman, CHF Scientific Review Committee. "A study of this scope is required to prove the efficacy of this plant-based therapy for dogs, and CHF is proud to take the lead on this research effort." 

CBD for pets has been growing in popularity as of late as more and more dog owners seek to provide their pooch with natural and effective treatments. CBD is used by dog owners to treat a wide variety of ailments including aggression disorders, self-trauma, cognitive problems, excessive vocalization, and even urination/marking problems.

The study, entitled, "Efficacy of Cannabidiol (CBD) for the Treatment of Canine Epilepsy," will run from October 1, 2017 - September 30, 2020, headed by Dr. Stephanie McGrath, a board-certified veterinary neurologist at Colorado State University’s College of Veterinary Medicine and Biomedical Sciences.